Futura Medical plc (FAMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.410
-0.020 (-4.65%)
Jan 21, 2025, 4:00 PM EST
Futura Medical Company Description
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health.
Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plc
| Country | United Kingdom |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12 |
| CEO | James Barder |
Contact Details
Address: Surrey Technology Centre Guildford, GU2 7YG United Kingdom | |
| Phone | 44 14 8368 5670 |
| Website | futuramedical.com |
Stock Details
| Ticker Symbol | FAMDF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB0033278473 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| James Henry Barder | Chief Executive Officer and Executive Director |
| Angela Hildreth | Chief Operating Officer, Finance Director, Company Secretary and Executive Director |
| Kenneth William James | Head of Research & Development and Executive Director |
| Dr. William Duncan Potter | Chief Scientific Officer and Adviser to the Board |
| Graham Smith | Head of Alliance Partnerships and Supply |
| Kevin Langridge | Head of Quality |